Hypoxic-Ischaemic Encephalopathy Not Yet Recruiting Phase 3 Trials for Erythropoietin (DB00016)

Also known as: Encephalopathy, Hypoxic-Ischemic / Hypoxic-Ischemic Encephalopathy / Hypoxic ischemic encephalopathy [HIE], unspecified / Hypoxic ischemic brain injury

IndicationStatusPhase
DBCOND0080116 (Hypoxic-Ischaemic Encephalopathy)Not Yet Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03163589Erythropoietin in Management of Neonatal Hypoxic Ischemic EncephalopathyTreatment